Join Fox News for access to this content Plus special access to select articles and other premium content with your account - free of charge. Please enter a valid email address. By entering your email and pushing continue, you are agreeing to Fox News' Terms of Use and Privacy Policy, which includes our Notice of
Lucid Diagnostics, a New York-based biotech company, is looking to revolutionize esophageal cancer prevention with a new test that only requires taking a single, vitamin-sized pill.
Lucid Diagnostics, a New York-based biotech company, is looking to revolutionize esophageal cancer prevention with a new test that only requires taking a single, vitamin-sized pill.